Literature DB >> 20425797

Sickle cell disease in the United States: looking back and forward at 100 years of progress in management and survival.

Hari Prabhakar1, Carlton Haywood, Robert Molokie.   

Abstract

The past 100 years since James Herrick's first description of sickle cell disease in the United States have been characterized by the gradual development of management strategies. We review the progress in sickle cell disease management in the United States over the past 100 years, with emphasis on the diverse forces surrounding advances in disease management. Mortality and survival data are presented chronologically, with an attempt to highlight improvements in survival associated with specific advancements for pediatric and adult care. Finally, the future course for sickle cell disease management is explored, given the continued work in advancing the field. (c) 2010 Wiley-Liss, Inc.

Mesh:

Substances:

Year:  2010        PMID: 20425797     DOI: 10.1002/ajh.21676

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  14 in total

1.  Fusobacterium nucleatum prosthetic hip infection in an adult with sickle cell-beta thalassemia.

Authors:  K Verma; P C McNabb; W Kurtz; J Green; C H Trabue
Journal:  Infection       Date:  2011-10-15       Impact factor: 3.553

2.  Understanding the Self-Management Practices of Young Adults with Sickle Cell Disease.

Authors:  Nadine Matthie; Coretta Jenerette
Journal:  J Sick Cell Dis Hemoglobinopathies       Date:  2017-05

Review 3.  Antibiotics for treating osteomyelitis in people with sickle cell disease.

Authors:  Arturo J Martí-Carvajal; Luis H Agreda-Pérez
Journal:  Cochrane Database Syst Rev       Date:  2016-11-14

Review 4.  Antibiotics for treating community-acquired pneumonia in people with sickle cell disease.

Authors:  Arturo J Martí-Carvajal; Lucieni O Conterno
Journal:  Cochrane Database Syst Rev       Date:  2016-11-14

Review 5.  Improving outcomes in children with sickle cell disease: treatment considerations and strategies.

Authors:  Ali Amid; Isaac Odame
Journal:  Paediatr Drugs       Date:  2014-08       Impact factor: 3.022

6.  Sickle cell disease in adults: developing an appropriate care plan.

Authors:  Nadine Matthie; Coretta Jenerette
Journal:  Clin J Oncol Nurs       Date:  2015-10       Impact factor: 1.027

7.  Autonomic nervous system reactivity: children with and without sickle cell disease.

Authors:  Marsha J Treadwell; Abbey Alkon; Lori Styles; W Thomas Boyce
Journal:  Nurs Res       Date:  2011 May-Jun       Impact factor: 2.381

8.  Sickle cell trait is not independently associated with susceptibility to end-stage renal disease in African Americans.

Authors:  Pamela J Hicks; Carl D Langefeld; Lingyi Lu; Anthony J Bleyer; Jasmin Divers; Patrick H Nachman; Vimal K Derebail; Donald W Bowden; Barry I Freedman
Journal:  Kidney Int       Date:  2011-08-17       Impact factor: 10.612

9.  Transition from pediatric to adult care in sickle cell disease: establishing evidence-based practice and directions for research.

Authors:  Marsha Treadwell; Joseph Telfair; Robert W Gibson; Shirley Johnson; Ifeyinwa Osunkwo
Journal:  Am J Hematol       Date:  2011-01       Impact factor: 10.047

10.  Red Blood Cell Adhesion to Heme-Activated Endothelial Cells Reflects Clinical Phenotype in Sickle Cell Disease.

Authors:  Erdem Kucukal; Anton Ilich; Nigel S Key; Jane A Little; Umut A Gurkan
Journal:  Am J Hematol       Date:  2018-06-15       Impact factor: 10.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.